← Leaderboards
Luanda P Grazette
Massachusetts General Hospital
$675,923
Attributed
$675,923
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$675,923 · 1
By mechanism
K01$675,923 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Tayyaba Hasan$21,611,486
- Ralph Weissleder$110,468,710
- Xandra Owens Breakefield$30,735,276
- Charalabos Pothoulakis$14,967,772
- Bob S Carter$9,693,982
Others in their field
Top investigators on “Tissue /Cell Culture”
- James R Gaines · University Of Hawaii At Manoa$24,999,553
- Jay B Jackson · Johns Hopkins University$22,308,100
- C Ronald Kahn · Joslin Diabetes Center$12,500,002
- George Stamatoyannopoulos · University Of Washington$11,744,799
- Laurie H Glimcher · Dana-Farber Cancer Inst$10,563,992
- Peter Karl Sorger · Massachusetts Institute Of Technology$9,821,548
Research focus
Tissue /Cell CultureDrug Adverse EffectMitogen Activated Protein KinaseMonoclonal AntibodyPhosphatidylinositol 3 KinaseProtooncogeneEpidermal Growth FactorGrowth Factor ReceptorsHeart FailureLaboratory RatReceptor ExpressionReceptor SensitivityApoptosisPostdoctoral InvestigatorProtein KinaseProtein Protein InteractionProtein Tyrosine KinaseCardiac MyocytesCardiotoxinCell Growth RegulationDoxorubicin
Grant awards (5)
The effect of erbB-2 receptor antagonism on cardiac via*$135,351
K01 · FY2005 · HL
The effect of erbB-2 receptor antagonism on cardiac via*$135,351
K01 · FY2004 · HL
The effect of erbB-2 receptor antagonism on cardiac via*$135,351
K01 · FY2003 · HL
The effect of erbB-2 receptor antagonism on cardiac via*$135,351
K01 · FY2002 · HL
The effect of erbB-2 receptor antagonism on cardiac via*$134,519
K01 · FY2001 · HL